Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.305 USD | -1.93% | +15.61% | +42.03% |
20/03 | North American Morning Briefing : Markets on Hold -2- | DJ |
19/03 | JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.03% | 412M | |
-1.11% | 104B | |
+6.77% | 97.47B | |
+5.71% | 22.25B | |
-12.90% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.63% | 16.36B | |
+8.50% | 14.39B | |
+39.86% | 12.37B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Mersana Therapeutics : Wedbush Adjusts Mersana Therapeutics' Price Target to $25 From $26, Keeps Outperform Rating